RSNA 2017 News

GE partners with Intel on digital imaging

By staff writers
November 26, 2017

GE Healthcare has announced an expanded partnership with Intel that aims to enhance patient care and reduce costs for hospitals and health systems using digital imaging software deployed via edge and cloud.

GE will use the new Intel Xeon Scalable software with the objective to lower the total cost for imaging ownership by 25%. Intel Xeon Scalable may improve radiologists' reading productivity compared with the prior generation by reducing first image display to less than 2 seconds, and full study load times down to less than 8 seconds.

GE Healthcare and Intel are also investing in a digital development lab in downtown Chicago. The Joint Performance Acceleration Lab (JPAL) will be dedicated to the development, testing, and validation of new innovations intended to help enable the highest radiology productivity at the lowest total cost of ownership.

The two companies will use Wind River Titanium Control software to allow hospitals and health systems to deploy more secure, edge solutions that improve agility and reduce operating costs, they added.

NVIDIA, GE expand partnership to focus on AI
NVIDIA and GE Healthcare are deepening their 10-year partnership with a new concentration on artificial intelligence (AI), which they announced at RSNA...
GE unveils new lightweight, flexible MR coil technology
GE Healthcare is touting a new foldable, lightweight MRI coil design based on what it calls adaptive imaging receive (AIR) technology. The result is flexible...
DiA Imaging Analysis partners with GE
Echocardiography image analysis developer DiA Imaging Analysis has signed a multiyear, nonexclusive licensing and professional services agreement with...
GE CEO: Healthcare core part of company's future
Healthcare is one of a core of businesses that industrial conglomerate GE plans to focus on in the coming years as the struggling industrial giant restructures,...
GE gets clearance for HD contrast mammography
GE Healthcare has received U.S. Food and Drug Administration 510(k) clearance for SenoBright HD, the latest version of its contrast-enhanced spectral...

Copyright © 2017